ArticleKidney medicine2024

Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety.

Kirk N Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.